Moreover, TWIST1, an important paralog of TWIST2, was involved in the fibrogenesis of keloid fibroblasts, and might serve as a therapeutic target of keloid (Liu et al., 2021), suggesting that TWIST2 might also be considered as a promising therapeutic target in HS. This evidence concerns the gene TWIST1 and histiocytic sarcoma.